Faculty

Back to Index
Siamak Daneshmand, MD
Associate Professor of Urology (Clinical Scholar)
Director of Clinical Research
Urology
NOR 7416 Health Sciences Campus Los Angeles
+1 323 865 3700

Overview

Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at the University of Southern California (USC) followed by a two-year fellowship in Urologic Oncology at the USC/Norris Comprehensive Cancer Center. He spent almost 6 years at Oregon Health and Science University where he established the Section of Urologic Oncology as a center of excellence for treatment of bladder and testis cancers. He was recruited to USC Institute of Urology in 2010 as Director of Urologic Oncology. He is currently an associate professor of urology with clinical scholar designation and serves as director of clinical research as well as the urologic oncology fellowship director. Dr. Daneshmand’s main interests include bladder cancer, advanced kidney cancer and testicular cancer. He has extensive experience in urinary diversion and reconstruction following surgical removal of the bladder (radical cystectomy) as well as nerve-sparing retroperitoneal lymph node dissection (RPLND) following chemotherapy for advanced testis cancer. He is one of the highest volume surgeons for this disease on the west coast. He has been selected as one of “True Experts” in the Testicular Cancer Resource Center web site. He also has extensive experience in the management of advanced kidney cancers with vena caval tumor thrombus involvement, as well as prostate cancer, retroperitoneal sarcomas and surgeries requiring replacement of the great vessels. He is a member of Alpha Omega Alpha medical honor society, and has been designated one of the “America’s Top Doctors” for several years. He is an active member of the Society of Urologic Oncology, has presented over 150 abstracts at scientific meetings and has authored over 120 peer-reviewed articles, reviews, and chapters. He is a reviewer for numerous urology journals.

Publications

Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, Pruthi R, Quale DZ, Ritch CR, Seigne JD, Skinner EC, Smith ND, McKiernan JM. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline. J Urol. 2016 Oct; 196(4):1021-9. View in: PubMed

Seiler R, Lam LL, Erho N, Takhar M, Mitra AP, Buerki C, Davicioni E, Skinner EC, Daneshmand S, Black PC. Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures. J Urol. 2016 Oct; 196(4):1036-41. View in: PubMed

Shahabi A, Lewinger JP, Ren J, April C, Sherrod AE, Hacia JG, Daneshmand S, Gill I, Pinski JK, Fan JB, Stern MC. Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients. Prostate. 2016 Oct; 76(14):1239-56. View in: PubMed

Hugen CM, Duddalwar V, Daneshmand S. Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy. Curr Urol Rep. 2016 Sep; 17(9):62. View in: PubMed

Feldman DR, Hu J, Dorff TB, Lim K, Patil S, Woo KM, Carousso M, Hughes A, Sheinfeld J, Bains M, Daneshmand S, Ketchens C, Bajorin DF, Bosl GJ, Quinn DI, Motzer RJ. Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors. J Clin Oncol. 2016 Jul 20; 34(21):2478-83. View in: PubMed

Djaladat H, Daneshmand S. Gastrointestinal Complications in Patients Who Undergo Radical Cystectomy with Enhanced Recovery Protocol. Curr Urol Rep. 2016 Jul; 17(7):50. View in: PubMed

Daneshmand S. Editorial Comment. J Urol. 2016 Jun; 195(6):1716. View in: PubMed

Zargar H, Zargar-Shoshtari K, Lotan Y, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black P. Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1? J Urol. 2016 Apr; 195(4P1):886-93. View in: PubMed

Movassaghi K, Shah SH, Cai J, Miranda G, Fernandez J, Duddalwar V, Daneshmand S, Djaladat H. Incisional and Parastomal Hernia Following Radical Cystectomy and Urinary Diversion: The USC Experience. J Urol. 2016 Apr 1. View in: PubMed

Satkunasivam R, Hu B, Metcalfe C, Ghodoussipour SB, Aron M, Cai J, Miranda G, Gill I, Daneshmand S. Utility and significance of ureteric frozen section analysis during radical cystectomy. BJU Int. 2016 Mar; 117(3):463-8. View in: PubMed

Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, Shariat SF, Zlotta AR, Boorjian SA. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Eur Urol. 2016 Feb; 69(2):300-10. View in: PubMed

Satkunasivam R, Santomauro M, Chopra S, Plotner E, Cai J, Miranda G, Salibian S, Aron M, Ginsberg D, Daneshmand S, Desai M, Gill IS. Robotic Intracorporeal Orthotopic Neobladder: Urodynamic Outcomes, Urinary Function, and Health-related Quality of Life. Eur Urol. 2016 Feb; 69(2):247-53. View in: PubMed

Zehnder P, Moltzahn F, Mitra AP, Cai J, Miranda G, Skinner EC, Gill IS, Daneshmand S. Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes. BJU Int. 2016 Feb; 117(2):253-9. View in: PubMed

Shahabi A, Satkunasivam R, Gill IS, Lieskovsky G, Daneshmand S, Pinski JK, Stern MC. Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the PSA-era. Can Urol Assoc J. 2016 Jan-Feb; 10(1-2):E17-22. View in: PubMed

Gakis G, Morgan TM, Efstathiou JA, Keegan KA, Mischinger J, Todenhoefer T, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Daneshmand S. Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma. World J Urol. 2016 Jan; 34(1):97-103. View in: PubMed

Gakis G, Efstathiou JA, Daneshmand S, Keegan KA, Clayman RH, Hrbacek J, Ali-El-Dein B, Zaid HB, Schubert T, Mischinger J, Todenhöfer T, Galland S, Olugbade K, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Morgan TM. Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma. Urol Int. 2016; 97(2):134-41. View in: PubMed

Hugen CM, Daneshmand S. Orthotopic urinary diversion in the elderly. World J Urol. 2016 Jan; 34(1):13-8. View in: PubMed

Hahn NM, Knudsen BS, Daneshmand S, Koch MO, Bihrle R, Foster RS, Gardner TA, Cheng L, Liu Z, Breen T, Fleming MT, Lance R, Corless CL, Alva AS, Shen SS, Huang F, Gertych A, Gallick GE, Mallick J, Ryan C, Galsky MD, Lerner SP, Posadas EM, Sonpavde G. Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity. Urol Oncol. 2016 Jan; 34(1):4. e11-7. View in: PubMed

Zargar-Shoshtari K, Zargar H, Lotan Y, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC. A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy. J Urol. 2016 Jan; 195(1):53-9. View in: PubMed

Xu W, Daneshmand S, Bazargani ST, Cai J, Miranda G, Schuckman AK, Djaladat H. Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway. J Urol. 2015 Nov; 194(5):1209-13. View in: PubMed

Daneshmand S. Orthotopic urinary diversion. Curr Opin Urol. 2015 Nov; 25(6):545-9. View in: PubMed

Daneshmand S. Urinary diversion 2015: controversies and new technologies: Choosing the 'right' diversion. Curr Opin Urol. 2015 Nov; 25(6):543-4. View in: PubMed

Hu B, Satkunasivam R, Schuckman A, Miranda G, Cai J, Daneshmand S. Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy. World J Urol. 2015 Oct; 33(10):1397-402. View in: PubMed

Simone G, Bianchi M, Giannarelli D, Daneshmand S, Papalia R, Ferriero M, Guaglianone S, Sentinelli S, Colombo R, Montorsi F, Collura D, Muto G, Novara G, Hurle R, Rink M, Fisch M, Abol-Enein H, Miranda G, Desai M, Gill I, Gallucci M. Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy. World J Urol. 2015 Oct; 33(10):1419-28. View in: PubMed

Hu B, Daneshmand S. Role of Extraretroperitoneal Surgery in Patients with Metastatic Germ Cell Tumors. Urol Clin North Am. 2015 Aug; 42(3):369-80. View in: PubMed

Skinner EC, Fairey AS, Groshen S, Daneshmand S, Cai J, Miranda G, Skinner DG. Randomized Trial of Studer Pouch versus T-Pouch Orthotopic Ileal Neobladder in Patients with Bladder Cancer. J Urol. 2015 Aug; 194(2):433-40. View in: PubMed

Daneshmand S. Role of surgical resection for refractory germ cell tumors. Urol Oncol. 2015 Aug; 33(8):370-8. View in: PubMed

Hu B, Shah S, Shojaei S, Daneshmand S. Retroperitoneal Lymph Node Dissection as First-Line Treatment of Node-Positive Seminoma. Clin Genitourin Cancer. 2015 Aug; 13(4):e265-9. View in: PubMed

Nguyen HG, Tilki D, Dall'Era MA, Durbin-Johnson B, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Linares Espinós E, Mandel P, Martinez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis. J Urol. 2015 Aug; 194(2):304-9. View in: PubMed

Shah SH, Movassaghi K, Skinner D, Dalag L, Miranda G, Cai J, Schuckman A, Daneshmand S, Djaladat H. Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience. Urology. 2015 Jul; 86(1):87-91. View in: PubMed

Satkunasivam R, Hu B, Daneshmand S. Is frozen section analysis of ureteral margins at time of radical cystectomy useful? Curr Urol Rep. 2015 Jun; 16(6):506. View in: PubMed

Niver BE, Daneshmand S, Satkunasivam R. Female reproductive organ-sparing radical cystectomy: contemporary indications, techniques and outcomes. Curr Opin Urol. 2015 Mar; 25(2):105-10. View in: PubMed

Sun AJ, Djaladat H, Schuckman A, Miranda G, Cai J, Daneshmand S. Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events. J Urol. 2015 Feb; 193(2):565-9. View in: PubMed

Zargar H, Espiritu PN, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Vasdev N, Yu EY, Youssef D, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Garcia JA, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC. Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. 2015 Feb; 67(2):241-9. View in: PubMed

Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Linares E, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Thieu W, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. J Urol. 2015 Feb; 193(2):436-42. View in: PubMed

Kollmannsberger C, Tandstad T, Bedard PL, Cohn-Cedermark G, Chung PW, Jewett MA, Powles T, Warde PR, Daneshmand S, Protheroe A, Tyldesley S, Black PC, Chi K, So AI, Moore MJ, Nichols CR. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance. J Clin Oncol. 2015 Jan 1; 33(1):51-7. View in: PubMed

Mitra AP, Alemozaffar M, Harris BN, Schuckman AK, Skinner EC, Daneshmand S. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. Urology. 2014 Dec; 84(6):1420-6. View in: PubMed

Hu B, Satkunasivam R, Schuckman A, Sherrod A, Cai J, Miranda G, Daneshmand S. Significance of perivesical lymph nodes in radical cystectomy for bladder cancer. Urol Oncol. 2014 Nov; 32(8):1158-65. View in: PubMed

Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Buerki C, Haddad Z, Sierocinski T, Triche TJ, Skinner EC, Davicioni E, Daneshmand S, Black PC. Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer. J Natl Cancer Inst. 2014 Nov; 106(11). View in: PubMed

Faber KD, Carlos C T R M, Cortessis VK, Daneshmand S. Validation of Surveillance, Epidemiology, and End Results TNM staging for testicular germ cell tumor. Urol Oncol. 2014 Nov; 32(8):1341-6. View in: PubMed

Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, Grossman HB, Kamat AM, Konety BR, Lee CT, Pohar KS, Pruthi RS, Resnick MJ, Smith ND, Witjes JA, Schoenberg MP, Steinberg GD. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014 Oct; 11(10):589-96. View in: PubMed

Patil MB, Montez J, Loh-Doyle J, Cai J, Skinner EC, Schuckman A, Thangathurai D, Skinner DG, Daneshmand S. Level III-IV Inferior Vena Caval Thrombectomy Without Cardiopulmonary Bypass: Long-Term Experience with Intrapericardial Control. J Urol. 2014 Sep; 192(3):682-9. View in: PubMed

Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. Impact of Histologic Subtype on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus. Eur Urol. 2014 Sep; 66(3):577-83. View in: PubMed

Lee DJ, Djaladat H, Tadros NN, Movassaghi M, Tejura T, Duddalwar V, Daneshmand S. Growing teratoma syndrome: Clinical and radiographic characteristics. Int J Urol. 2014 Sep; 21(9):905-8. View in: PubMed

Ahmadi H, Djaladat H, Cai J, Miranda G, Daneshmand S. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: Prognostic value in invasive urothelial carcinoma of the bladder. Urol Oncol. 2014 Jul; 32(5):648-56. View in: PubMed

Ploussard G, Daneshmand S, Efstathiou JA, Herr HW, James ND, Rödel CM, Shariat SF, Shipley WU, Sternberg CN, Thalmann GN, Kassouf W. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Eur Urol. 2014 Jul; 66(1):120-37. View in: PubMed

Daneshmand S, Ahmadi H, Schuckman AK, Mitra AP, Cai J, Miranda G, Djaladat H. Enhanced recovery protocol after radical cystectomy for bladder cancer. J Urol. 2014 Jul; 192(1):50-6. View in: PubMed

Djaladat H, Bruins HM, Miranda G, Cai J, Skinner EC, Daneshmand S. The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer. BJU Int. 2014 Jun; 113(6):887-93. View in: PubMed

Zehnder P, Studer UE, Daneshmand S, Birkhäuser FD, Skinner EC, Roth B, Miranda G, Burkhard FC, Cai J, Skinner DG, Thalmann GN, Gill IS. Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. BJU Int. 2014 Apr; 113(4):554-60. View in: PubMed

Su SF, de Castro Abreu AL, Chihara Y, Tsai Y, Andreu-Vieyra C, Daneshmand S, Skinner EC, Jones PA, Siegmund KD, Liang G. A panel of three markers hyper- and hypomethylated in urine sediments accurately predicts bladder cancer recurrence. Clin Cancer Res. 2014 Apr 1; 20(7):1978-89. View in: PubMed

Xylinas E, Kluth LA, Lotan Y, Daneshmand S, Rieken M, Karakiewicz PI, Shariat SF. Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder. Urol Oncol. 2014 Apr; 32(3):230-42. View in: PubMed

Lay FD, Triche TJ, Tsai YC, Su SF, Martin SE, Daneshmand S, Skinner EC, Liang G, Chihara Y, Jones PA. Reprogramming of the human intestinal epigenome by surgical tissue transposition. Genome Res. 2014 Apr; 24(4):545-53. View in: PubMed

Djaladat H, Daneshmand S. Enhanced recovery pathway following radical cystectomy. Curr Opin Urol. 2014 Mar; 24(2):135-9. View in: PubMed

Djaladat H, Movassaghi K, Ahmadi H, Nichols CR, Daneshmand S. Mesenteric lymphadenopathy in testicular germ cell tumor. Urology. 2014 Mar; 83(3):e7-8. View in: PubMed

Mitra AP, Bartsch CC, Bartsch G, Miranda G, Skinner EC, Daneshmand S. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. Urol Oncol. 2014 Feb; 32(2):117-27. View in: PubMed

Fairey AS, Daneshmand S, Skinner EC, Schuckman A, Cai J, Lieskovsky G. Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era. Urol Oncol. 2014 Feb; 32(2):85-91. View in: PubMed

Bartsch G, Daneshmand S, Skinner EC, Syan S, Skinner DG, Penson DF. Urinary functional outcomes in female neobladder patients. World J Urol. 2014 Feb; 32(1):221-8. View in: PubMed

Fairey AS, Daneshmand S, Wang L, Schuckman A, Lieskovsky G, Djaladat H, Cai J, Miranda G, Skinner EC. Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy. Urol Oncol. 2014 Feb; 32(2):110-6. View in: PubMed

Culp SH, Dickstein RJ, Grossman HB, Pretzsch SM, Porten S, Daneshmand S, Cai J, Groshen S, Siefker-Radtke A, Millikan RE, Czerniak B, Navai N, Wszolek MF, Kamat AM, Dinney CP. Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy. J Urol. 2014 Jan; 191(1):40-7. View in: PubMed

Vashistha V, Quinn DI, Dorff TB, Daneshmand S. Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review. BMC Cancer. 2014; 14:966. View in: PubMed

Lee RK, Abol-Enein H, Artibani W, Bochner B, Dalbagni G, Daneshmand S, Fradet Y, Hautmann RE, Lee CT, Lerner SP, Pycha A, Sievert KD, Stenzl A, Thalmann G, Shariat SF. Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU Int. 2014 Jan; 113(1):11-23. View in: PubMed

Bruins HM, Skinner EC, Dorin RP, Ahmadi H, Djaladat H, Miranda G, Cai J, Daneshmand S. Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: Results from a prospective lymph node mapping study. Urol Oncol. 2014 Jan; 32(1):24. e13-9. View in: PubMed

Ahmadi H, Daneshmand S. Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes. Patient Relat Outcome Meas. 2014; 5:63-70. View in: PubMed

Mitra AP, Skinner EC, Schuckman AK, Quinn DI, Dorff TB, Daneshmand S. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: A critical analysis of 1,994 patients. Urol Oncol. 2014 Jan; 32(1):52. e1-9. View in: PubMed

Zehnder P, Moltzahn F, Daneshmand S, Leahy M, Cai J, Miranda G, Bartsch G, Mitra AP, Skinner DG, Skinner EC, Gill IS. Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy. BJU Int. 2014 Jan; 113(1):65-9. View in: PubMed

Daneshmand S. Editorial comment. Urology. 2013 Dec; 82(6):1346. View in: PubMed

Djaladat H, Mitra AP, Miranda G, Skinner EC, Daneshmand S. Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: Oncological outcomes. Int J Urol. 2013 Dec; 20(12):1229-33. View in: PubMed

Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M, Xylinas E, Chromecki TF, Breinl E, Svatek RS, Donner G, Tagawa ST, Tilki D, Bastian PJ, Karakiewicz PI, Volkmer BG, Novara G, Joual A, Faison T, Sonpavde G, Daneshmand S, Lotan Y, Scherr DS, Shariat SF. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. Eur Urol. 2013 Nov; 64(5):837-45. View in: PubMed

Bruins HM, Djaladat H, Ahmadi H, Sherrod A, Cai J, Miranda G, Skinner EC, Daneshmand S. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens. J Urol. 2013 Nov; 190(5):1704-9. View in: PubMed

Dorin RP, Lieskovsky G, Fairey AS, Cai J, Daneshmand S. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era. Urol Oncol. 2013 Nov; 31(8):1441-7. View in: PubMed

Fairey AS, Daneshmand S, Quinn D, Dorff T, Dorin R, Lieskovsky G, Schuckman A, Cai J, Miranda G, Skinner EC. Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California. Urol Oncol. 2013 Nov; 31(8):1737-43. View in: PubMed

Thomas JP, Davis-Dao C, Lewinger JP, Siegmund KD, Hamilton AS, Daneshmand S, Skinner EC, Thomas DC, Cortessis VK. Null association between histology of first and second primary malignancies in men with bilateral testicular germ cell tumors. Am J Epidemiol. 2013 Oct 15; 178(8):1240-5. View in: PubMed

Nichols CR, Roth B, Albers P, Einhorn LH, Foster R, Daneshmand S, Jewett M, Warde P, Sweeney CJ, Beard C, Powles T, Tyldesley S, So A, Porter C, Olgac S, Fizazi K, Hayes-Lattin B, Grimison P, Toner G, Cathomas R, Bokemeyer C, Kollmannsberger C. Active surveillance is the preferred approach to clinical stage I testicular cancer. J Clin Oncol. 2013 Oct 1; 31(28):3490-3. View in: PubMed

Daneshmand S. Editorial comment. J Urol. 2013 Sep; 190(3):927. View in: PubMed

Zehnder P, Studer UE, Skinner EC, Thalmann GN, Miranda G, Roth B, Cai J, Birkhäuser FD, Mitra AP, Burkhard FC, Dorin RP, Daneshmand S, Skinner DG, Gill IS. Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU Int. 2013 Jul; 112(2):E51-8. View in: PubMed

Daneshmand S, Gill IS. Minimally invasive postchemotherapy retroperitoneal lymph node dissection: caution and prudence. Eur Urol. 2013 Jun; 63(6):1018-9; discussion 1020. View in: PubMed

Daneshmand S. Determining the role of cystectomy for high-grade T1 urothelial carcinoma. Urol Clin North Am. 2013 May; 40(2):233-47. View in: PubMed

Ahmadi H, Skinner EC, Simma-Chiang V, Miranda G, Cai J, Penson DF, Daneshmand S. Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients. J Urol. 2013 May; 189(5):1782-8. View in: PubMed

Daneshmand S, Ahmadi H. Conversion from incontinent conduit to continent cutaneous reservoir after renal transplant. Urology. 2013 May; 81(5):1086-9. View in: PubMed

Ahmadi H, Daneshmand S. Androgen deprivation therapy: evidence-based management of side effects. BJU Int. 2013 Apr; 111(4):543-8. View in: PubMed

Ahmadi H, Mitra AP, Abdelsayed GA, Cai J, Djaladat H, Bruins HM, Daneshmand S. Principal component analysis based pre-cystectomy model to predict pathological stage in patients with clinical organ-confined bladder cancer. BJU Int. 2013 Apr; 111(4 Pt B):E167-72. View in: PubMed

Daneshmand S. Editorial comment. J Urol. 2013 Apr; 189(4):1318-9. View in: PubMed

Bruins HM, Wopat R, Mitra AP, Cai J, Miranda G, Skinner EC, Daneshmand S. Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy. BJU Int. 2013 Mar; 111(3 Pt B):E37-42. View in: PubMed

Shariat SF, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger AS, Svatek RS, Cha EK, Tagawa ST, Fajkovic H, Novara G, Karakiewicz PI, Trinh QD, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Chun FK, Sonpavde G, Joual A, Scherr DS, Gonen M. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. Eur Urol. 2013 Feb; 63(2):371-8. View in: PubMed

Mitra AP, Skinner EC, Miranda G, Daneshmand S. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. BJU Int. 2013 Feb; 111(2):240-8. View in: PubMed

Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche HM, Burger M, Izawa JI, Brisuda A, Babjuk M, Pummer K, Shariat SF. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJU Int. 2013 Feb; 111(2):249-55. View in: PubMed

Rink M, Hansen J, Cha EK, Green DA, Babjuk M, Svatek RS, Xylinas E, Tagawa ST, Faison T, Novara G, Karakiewicz PI, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Comploj E, Tilki D, Bastian PJ, Chun FK, Dahlem R, Scherr DS, Shariat SF. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. BJU Int. 2013 Jan; 111(1):74-84. View in: PubMed

Suriano F, Daneshmand S, Buscarini M. Use of nonabsorbable staples for urinary diversion: a step in the wrong direction. Urol Int. 2013; 90(2):125-9. View in: PubMed

Rink M, Shariat SF, Xylinas E, Fitzgerald JP, Hansen J, Green DA, Kamat AM, Novara G, Daneshmand S, Fradet Y, Tagawa ST, Bastian PJ, Kassouf W, Trinh QD, Karakiewicz PI, Fritsche HM, Tilki D, Chun FK, Volkmer BG, Babjuk M, Merseburger AS, Scherr DS, Lotan Y, Svatek RS. Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol. 2012 Dec; 30(6):807-14. View in: PubMed

Djaladat H, Bruins HM, Miranda G, Cai J, Skinner EC, Daneshmand S. Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer. J Urol. 2012 Dec; 188(6):2134-8. View in: PubMed

Huang EY, Skinner EC, Boyd SD, Cai J, Miranda G, Daneshmand S. Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy. World J Urol. 2012 Dec; 30(6):741-5. View in: PubMed

Daneshmand S, Ahmadi H, Huynh LN, Dobos N. Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Urology. 2012 Dec; 80(6):1313-8. View in: PubMed

Goh AC, Gill IS, Lee DJ, de Castro Abreu AL, Fairey AS, Leslie S, Berger AK, Daneshmand S, Sotelo R, Gill KS, Xie HW, Chu LY, Aron M, Desai MM. Robotic intracorporeal orthotopic ileal neobladder: replicating open surgical principles. Eur Urol. 2012 Nov; 62(5):891-901. View in: PubMed

Daneshmand S, Albers P, Fosså SD, Heidenreich A, Kollmannsberger C, Krege S, Nichols C, Oldenburg J, Wood L. Contemporary management of postchemotherapy testis cancer. Eur Urol. 2012 Nov; 62(5):867-76. View in: PubMed

Daneshmand S. Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience. BJU Int. 2012 Nov; 110(9):1324. View in: PubMed

Bruins HM, Dorin RP, Rubino B, Miranda G, Cai J, Daneshmand S, Skinner EC. Critical Evaluation of the American Joint Committee on Cancer TNM Nodal Staging System in Patients with Lymph Node-Positive Disease after Radical Cystectomy. Eur Urol. 2012 Oct; 62(4):671-6. View in: PubMed

Kim P, Syan-Bhanvadia S, Djaladat H, Faber K, Tadros NN, Nichols C, Daneshmand S. Midline extraperitoneal approach for retroperitoneal lymph node dissection for testicular germ cell tumor. Urology. 2012 Oct; 80(4):941-5. View in: PubMed

Rink M, Ehdaie B, Cha EK, Green DA, Karakiewicz PI, Babjuk M, Margulis V, Raman JD, Svatek RS, Fajkovic H, Lee RK, Novara G, Hansen J, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Fisch M, Scherr DS, Shariat SF. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol. 2012 Oct; 62(4):677-84. View in: PubMed

Daneshmand S. Editorial comment. Urology. 2012 Sep; 80(3):639. View in: PubMed

Meeks JJ, Bellmunt J, Bochner BH, Clarke NW, Daneshmand S, Galsky MD, Hahn NM, Lerner SP, Mason M, Powles T, Sternberg CN, Sonpavde G. A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. 2012 Sep; 62(3):523-33. View in: PubMed

Djaladat H, Nichols C, Daneshmand S. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection. Ann Surg Oncol. 2012 Jul; 19(7):2388-93. View in: PubMed

Daneshmand S. The value of extended transurethral resection of bladder tumour (turbt) in the treatment of bladder cancer. BJU Int. 2012 Jul; 110(2 Pt B):E80. View in: PubMed

Mitra AP, Quinn DI, Dorff TB, Skinner EC, Schuckman AK, Miranda G, Gill IS, Daneshmand S. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU Int. 2012 Mar; 109(6):846-54. View in: PubMed

Dorin RP, Daneshmand S, Lassoff MA, Cai J, Skinner DG, Lieskovsky G. Long-term Outcomes of Open Radical Retropubic Prostatectomy for Clinically Localized Prostate Cancer in the Prostate-specific Antigen Era. Urology. 2012 Mar; 79(3):626-31. View in: PubMed

Daneshmand S. Editorial comment. Urology. 2012 Feb; 79(2):481. View in: PubMed

Shariat SF, Ehdaie B, Rink M, Cha EK, Svatek RS, Chromecki TF, Fajkovic H, Novara G, David SG, Daneshmand S, Fradet Y, Lotan Y, Sagalowsky AI, Clozel T, Bastian PJ, Kassouf W, Fritsche HM, Burger M, Izawa JI, Tilki D, Abdollah F, Chun FK, Sonpavde G, Karakiewicz PI, Scherr DS, Gonen M. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. Eur Urol. 2012 Feb; 61(2):237-42. View in: PubMed

Zhuang L, Duty BD, Conlin MJ, Daneshmand S. Colocalycostomy for repair of ureterojejunal fistula. Urology. 2012 Feb; 79(2):e12-4. View in: PubMed

Loh-Doyle JC, Patil MB, Daneshmand S. Renal cell carcinoma with inferior vena cava tumor thrombus and metastatic caval wall invasion. Urology. 2012 Feb; 79(2):e6-8. View in: PubMed

Banks K, Tuazon E, Berhane K, Koh CJ, De Filippo RE, Chang A, Kim SS, Daneshmand S, Davis-Dao C, Lewinger JP, Bernstein L, Cortessis VK. Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics. Front Endocrinol (Lausanne). 2012; 3:182. View in: PubMed

Djaladat H, Nichols CR, Daneshmand S. Chemoresponsive liver hemangioma in a patient with a metastatic germ cell tumor. J Clin Oncol. 2011 Dec 10; 29(35):e842-4. View in: PubMed

Dorin RP, Daneshmand S, Eisenberg MS, Chandrasoma S, Cai J, Miranda G, Nichols PW, Skinner DG, Skinner EC. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol. 2011 Nov; 60(5):946-52. View in: PubMed

Daneshmand S, Stephenson AJ, Sheinfeld J, Jewett MA. The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation. Urol Oncol. 2011 Nov; 29(6):842-7. View in: PubMed

Zehnder P, Studer UE, Skinner EC, Dorin RP, Cai J, Roth B, Miranda G, Birkhäuser F, Stein J, Burkhard FC, Daneshmand S, Thalmann GN, Gill IS, Skinner DG. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol. 2011 Oct; 186(4):1261-8. View in: PubMed

Daneshmand S, Djaladat H, Nichols C. Management of residual mass in nonseminomatous germ cell tumors following chemotherapy. Ther Adv Urol. 2011 Aug; 3(4):163-71. View in: PubMed

Djaladat H, Nichols C, Daneshmand S. Androgen-producing testicular germ cell tumors. J Clin Oncol. 2011 Jul 20; 29(21):e634-5. View in: PubMed

Daneshmand S, Bartsch G. Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer. Expert Rev Anticancer Ther. 2011 Jun; 11(6):941-8. View in: PubMed

Daneshmand S, Djaladat H, Porter CR, Nichols C. Evaluation and Preservation of Fertility in Patients with Testicular Cancer. J Adolesc Young Adult Oncol. 2011 Mar; 1(1):25-9. View in: PubMed

Schreiner A, Daneshmand S, Bayne A, Countryman G, Corless CL, Troxell ML. Distinctive morphology of renal cell carcinomas in tuberous sclerosis. Int J Surg Pathol. 2010 Oct; 18(5):409-18. View in: PubMed

Daneshmand S. Editorial comment. Urology. 2010 Oct; 76(4):1001. View in: PubMed

Ashley MS, Daneshmand S. Factors influencing the choice of urinary diversion in patients undergoing radical cystectomy. BJU Int. 2010 Sep; 106(5):654-7. View in: PubMed

Kollmannsberger C, Daneshmand S, So A, Chi KN, Murray N, Moore C, Hayes-Lattin B, Nichols C. Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery. J Clin Oncol. 2010 Feb 1; 28(4):537-42. View in: PubMed

Duty B, Daneshmand S. Resection of the inferior vena cava without reconstruction for urologic malignancies. Urology. 2009 Dec; 74(6):1257-62. View in: PubMed

Ashley MS, Daneshmand S. Re: Appendiceal substitution following right proximal ureter injury. Int Braz J Urol. 2009 Jan-Feb; 35(1):90-1. View in: PubMed

Ashley MS, Moneta G, Daneshmand S. Open partial nephrectomy for pediatric renovascular hypertension. ScientificWorldJournal. 2009; 9:287-90. View in: PubMed

Duty B, Daneshmand S. Venous resection in urological surgery. J Urol. 2008 Dec; 180(6):2338-42; discussion 2342. View in: PubMed

Daneshmand S. Words of wisdom. Re: use of androgen deprivation therapy for metastatic prostate cancer in older men. Eur Urol. 2008 Nov; 54(5):1201-2. View in: PubMed

Wagner M, Bayne A, Daneshmand S. Application of the Yang-Monti channel in adult continent cutaneous urinary diversion. Urology. 2008 Oct; 72(4):828-31. View in: PubMed

Daneshmand S, Quek ML, Lin E, Lee C, Cote RJ, Hawes D, Cai J, Groshen S, Lieskovsky G, Skinner DG, Lee AS, Pinski J. Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Hum Pathol. 2007 Oct; 38(10):1547-52. View in: PubMed

Wagner MD, Daneshmand S, Sokoloff M, Barry JM. Re: Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. S. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona, J Urol 2006; 176: 1399-1403. J Urol. 2007 Jun; 177(6):2396; author reply 2396-7. View in: PubMed

Bayne A, Koslin B, Daneshmand S. Bilateral segmental testicular infarction. ScientificWorldJournal. 2007; 7:779-83. View in: PubMed

Moore CJ, Daneshmand S, Kondagunta GV, Nichols CR. Management of difficult germ-cell tumors. Oncology (Williston Park). 2006 Nov; 20(12):1565-70, 1575; discussion 1575-6. View in: PubMed

Dorff TB, Quek ML, Daneshmand S, Pinski J. Evolving treatment paradigms for locally advanced and metastatic prostate cancer. Expert Rev Anticancer Ther. 2006 Nov; 6(11):1639-51. View in: PubMed

Quek ML, Daneshmand S, Rodrigo S, Cai J, Dorff TB, Groshen S, Skinner DG, Lieskovsky G, Pinski J. Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer. Urology. 2006 Jun; 67(6):1247-52. View in: PubMed

Quek ML, Stein JP, Daneshmand S, Miranda G, Thangathurai D, Roffey P, Skinner EC, Lieskovsky G, Skinner DG. A critical analysis of perioperative mortality from radical cystectomy. J Urol. 2006 Mar; 175(3 Pt 1):886-9; discussion 889-90. View in: PubMed

Komanapalli CB, Tripathy U, Sokoloff M, Daneshmand S, Das A, Slater MS. Intraoperative renal cell carcinoma tumor embolization to the right atrium: incidental diagnosis by transesophageal echocardiography. Anesth Analg. 2006 Feb; 102(2):378-9. View in: PubMed

Daneshmand S, Quek ML. Adrenal myelolipoma: diagnosis and management. Urol J. 2006; 3(2):71-4. View in: PubMed

Sokoloff MH, Daneshmand S, Ryan CW. Current clinical trials in renal cell carcinoma. Urol Oncol. 2005 Jul-Aug; 23(4):289-92. View in: PubMed

Quek ML, Stein JP, Nichols PW, Cai J, Miranda G, Groshen S, Daneshmand S, Skinner EC, Skinner DG. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol. 2005 Jul; 174(1):103-6. View in: PubMed

Quek ML, Nichols PW, Yamzon J, Daneshmand S, Miranda G, Cai J, Groshen S, Stein JP, Skinner DG. Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience. J Urol. 2005 Jul; 174(1):93-6. View in: PubMed

Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V, Quinn DI, Henshall SM, Sutherland RL, Pinski JK, Daneshmand S, Buscarini M, Stein JP, Zhong C, Broek D, Roy-Burman P, Gill PS. EphB4 expression and biological significance in prostate cancer. Cancer Res. 2005 Jun 1; 65(11):4623-32. View in: PubMed

Daneshmand S, Dorff TB, Quek ML, Cai J, Pike MC, Nichols PW, Pinski J. Ethnic differences in neuroendocrine cell expression in normal human prostatic tissue. Urology. 2005 May; 65(5):1008-12. View in: PubMed

Daneshmand S, Quek ML, Stein JP, Lieskovsky G, Cai J, Pinski J, Skinner EC, Skinner DG. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol. 2004 Dec; 172(6 Pt 1):2252-5. View in: PubMed

Quek ML, Sanderson KM, Daneshmand S, Stein JP. The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer. Expert Rev Anticancer Ther. 2004 Dec; 4(6):1007-16. View in: PubMed

Chandrasoma S, Daneshmand S, Wilson S, Skinner EC. Renal angiomyolipoma with liposarcomatous transformation: a case report and review of the literature. Urol Oncol. 2004 Sep-Oct; 22(5):425-7. View in: PubMed

Quek ML, Sanderson K, Daneshmand S, Stein JP. New molecular markers for bladder cancer detection. Curr Opin Urol. 2004 Sep; 14(5):259-64. View in: PubMed

Chandrasoma S, Moatamed N, Chang A, Daneshmand S, Ma Y. Angiomyolipoma of the kidney: expanding disease spectrum demonstrated by 3 cases. Appl Immunohistochem Mol Morphol. 2004 Sep; 12(3):277-83. View in: PubMed

Daneshmand S, Stein JP, Lesser T, Quek ML, Nichols PW, Miranda G, Cai J, Groshen S, Skinner EC, Skinner DG. Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder. J Urol. 2004 Jul; 172(1):81-4. View in: PubMed

Daneshmand S. Adenomatous polyp of the verumontanum causing bladder outlet obstruction. ScientificWorldJournal. 2004 Jun 7; 4 Suppl 1:89-91. View in: PubMed

Daneshmand S, Chandrasoma S, Wilson S. Primary renal carcinoid tumor. ScientificWorldJournal. 2004 Jun 3; 4:378-80. View in: PubMed

Tchelepi H, Daneshmand S, Yanle Z, Ralls PW. Sonography of spermatic cord leiomyoma: case report and review of the literature. J Ultrasound Med. 2004 Apr; 23(4):569-71. View in: PubMed

Stein JP, Daneshmand S, Dunn M, Garcia M, Lieskovsky G, Skinner DG. Continent right colon reservoir using a cutaneous appendicostomy. Urology. 2004 Mar; 63(3):577-80; discussion 580-1. View in: PubMed

Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Cote RJ, Lieskovsky G, Quinn DI, Skinner DG. Microscopic and gross extravesical extension in pathological staging of bladder cancer. J Urol. 2004 Feb; 171(2 Pt 1):640-5. View in: PubMed

Daneshmand S, Youssefzadeh D, Chamie K, Boswell W, Wu N, Stein JP, Boyd S, Skinner DG. Benign retroperitoneal schwannoma: a case series and review of the literature. Urology. 2003 Dec; 62(6):993-7. View in: PubMed

Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Lieskovsky G, Quinn DI, Raghavan D, Skinner DG. Natural history of surgically treated bladder carcinoma with extravesical tumor extension. Cancer. 2003 Sep 1; 98(5):955-61. View in: PubMed

Quek ML, Shpall AI, Daneshmand S. Colourachal fistula in an adult presenting with feculent umbilical drainage. J Urol. 2003 Jul; 170(1):184. View in: PubMed

Daneshmand S, Quek ML, Huffman JL. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer. 2003 Jul 1; 98(1):55-60. View in: PubMed

Daneshmand S, Chandrasoma S, Lum C. Sarcomatoid renal cell carcinoma with massive osteosarcomatous differentiation: an unusual image in clinical urology. Urology. 2003 May; 61(5):1031-2. View in: PubMed

Daneshmand S, Ginsberg DA, Bennet JK, Foote J, Killorin W, Rozas KP, Green BG. Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinence. J Urol. 2003 Jan; 169(1):199-202. View in: PubMed

Daneshmand S, Huffman JL. Endoscopic management of renal hemangioma. J Urol. 2002 Feb; 167(2 Pt 1):488-9. View in: PubMed

Daneshmand S, Youssefzadeh D, Skinner EC. Review of techniques to remove a Foley catheter when the balloon does not deflate. Urology. 2002 Jan; 59(1):127-9. View in: PubMed

Powered bySC CTSI